Skip to main content

Table 2 Genomic losses found in more than 10 % of BRCAX breast tumors

From: Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival

Chromosome

CytoBand

Start

Stop

Size bp

Percentage of BRCAX tumors (N = 40)

Candidate tumor suppressor genes

Other genes

1

p31.1

78765816

79106841

341,025

12.5

 

PTGFR, IFI44L, IFI44

q21.2

148392365

148504936

112,571

22.5

PLEKHO1, APH1A

ANP32E, CA14

q24.2

167969938

168079511

109,573

12.5

 

C1orf156, C1orf112

3

q25.1

152529936

152650652

120,716

12.5

 

MED12L,P2RY13, P2RY12, IGSF10

6

p21.32

32897974

32905723

7749

15.0

 

TAP2

p21.32

32918832

32929682

10,850

17.5

PSMB8

TAP1

p21.32

32932575

33057062

124,487

15.0

HLA-DMB

PSMB9, BRD2

p22.1

27200902

27210109

9207

20.0

 

HIST1H2BJ, HIST1H2AG

7

q34

141051502

141137338

85,836

17.5

SSBP1

WEE2, TAS2R3, TAS2R4, TAS2R5

9

q32

116094655

116176804

82,149

15.0

 

COL27A1, ORM1, ORM2, AKNA

11

q23.3

114614479

116165823

1,551,344

15.0

CADM1

BUD13, ZPR1, APOA5

12

q13.2

54429832

54500555

70,723

12.5

 

GDF11, CIP29, ORMDL2

13

q21.1

52406170

52944596

538,426

12.5

 

OLFM4

14

q11.2

22424322

22467920

43,598

15.0

 

REM2, RBM23, PRMT5

15

q11.2

20477397

20599137

121,740

15.0

CYFIP1

NIPA2, NIPA1

16

q12.1

50773858

51032886

259,028

15.0

 

TOX3

17

q25.1

68713135

68845671

132,536

20.0

 

COG1, FAM104A, C17orf80, CDC42EP4, SDK2

20

q12

39100100

39142168

42,068

22.5

 

TOP1

q12

39201874

39331155

129,281

12.5

 

PLCG1, ZHX3

22

q11.21

19683237

19692296

9059

12.5

 

LZTR1, THAP7

  1. Most frequent losses in BRCAX tumors are highlighted in bold